- Home
- INDI vs RGC Comparison
INDI vs RGC Comparison
Compare INDI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- RGC
- Stock Information
- Founded
- INDI 2007
- RGC 2014
- Country
- INDI United States
- RGC Hong Kong
- Employees
- INDI N/A
- RGC N/A
- Industry
- INDI Semiconductors
- RGC Medicinal Chemicals and Botanical Products
- Sector
- INDI Technology
- RGC Health Care
- Exchange
- INDI Nasdaq
- RGC Nasdaq
- Market Cap
- INDI 381.6M
- RGC 377.5M
- IPO Year
- INDI N/A
- RGC 2021
- Fundamental
- Price
- INDI $2.33
- RGC $366.01
- Analyst Decision
- INDI Strong Buy
- RGC
- Analyst Count
- INDI 6
- RGC 0
- Target Price
- INDI $7.50
- RGC N/A
- AVG Volume (30 Days)
- INDI 2.3M
- RGC 128.1K
- Earning Date
- INDI 05-12-2025
- RGC 06-20-2025
- Dividend Yield
- INDI N/A
- RGC N/A
- EPS Growth
- INDI N/A
- RGC N/A
- EPS
- INDI N/A
- RGC N/A
- Revenue
- INDI $216,682,000.00
- RGC N/A
- Revenue This Year
- INDI $25.15
- RGC N/A
- Revenue Next Year
- INDI $49.44
- RGC N/A
- P/E Ratio
- INDI N/A
- RGC N/A
- Revenue Growth
- INDI N/A
- RGC N/A
- 52 Week Low
- INDI $1.53
- RGC $3.03
- 52 Week High
- INDI $7.82
- RGC $250.00
- Technical
- Relative Strength Index (RSI)
- INDI 60.44
- RGC 93.65
- Support Level
- INDI $1.96
- RGC $27.70
- Resistance Level
- INDI $2.10
- RGC $250.00
- Average True Range (ATR)
- INDI 0.13
- RGC 40.23
- MACD
- INDI 0.07
- RGC 29.16
- Stochastic Oscillator
- INDI 72.22
- RGC 96.17
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.